Expedite is a fee for service business development entity working in the animal health space. In the case of Expedite, business development takes on a very broad definition including technology scouting, technology assessment, and, for those assets offering commercial value, assistance in their development to a valuation point, be that registration and commercialization or out-licensure, working with biologicals, pharmaceuticals, topical pesticides, devices, and "nutraceuticals," among others. Expedite serves the animal health industry by “de-risking” early stage opportunities ranging from specific technologies to complete companies. Expedite analyzes these technologies to identify necessary advances that are needed to arrive at a point at which a more informed decision can be made regarding further investment. As a portal into the animal health business, Expedite clients range from small, startup companies seeking to enter the space to multinational companies seeking to expand their capabilities to identify and acquire meaningful assets.Expedite accomplishes these goals by utilizing a cadre of competent individuals with direct experience in the animal health industry. This collection of subject matter experts provides expertise in science, regulatory, manufacturing, legal (intellectual property and freedom to operate), technical services, sales, and marketing in a business development environment. These experts can direct necessary work with the project innovators, contract organizations, or work with a client company’s own employees.Expedite is well positioned in the changing animal health environment and is not bound to organizational paradigms but poised to navigate the environments in which it operates. The company operates as a valued partner providing meaningful input to clients at all levels and stages of the animal health industry in order to bring valuable and viable technology to commercialization in the most expeditious manner.